Filed 3.0y ago· Jun 6, 2023
12 days to disclose
Zoe Lofgren
DHouseCalifornia-18
↓sold
Gilead Sciences
GILD
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–7 of 7
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Merck
MRK
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Stock
Filed 3.0y ago· Jun 6, 2023
12 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Pfizer
PFE
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Filed 3.6y ago· Oct 11, 2022
32 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Gilead Sciences
GILD
$1K-$15K
+93.2% vs S&P 500
Trade dateSep 9, 2022
Filed 4.6y ago· Nov 3, 2021
21 days to discloseZoe Lofgren
DHouseCalifornia-18
↓sold
Pfizer
PFE
$1K-$15K
+18.3% vs S&P 500
Trade dateOct 13, 2021
Filed 4.7y ago· Oct 7, 2021
7 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Merck
MRK
$1K-$15K
+34.5% vs S&P 500
Trade dateSep 30, 2021
Stock
Filed 4.7y ago· Oct 7, 2021
7 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Pfizer
PFE
$1K-$15K
−55.0% vs S&P 500
Trade dateSep 30, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Gilead Sciences GILD | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Merck MRK Stock | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Pfizer PFE | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Gilead Sciences GILD | Sep 9, 2022 32 days to disclose | Good buy·+$8.6K+107.0% +93.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 3, 2021 4.6y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Pfizer PFE | Oct 13, 2021 21 days to disclose | Flat·+0.0% +18.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Merck MRK Stock | Sep 30, 2021 7 days to disclose | Good buy·+$4.1K+51.2% +34.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Pfizer PFE | Sep 30, 2021 7 days to disclose | Bad buy·−$3.1K-38.3% −55.0% vs S&P 500 | $1K-$15K midpoint $8K |